logo
Share SHARE
FONT-SIZE Plus   Neg

Henkel Backs 2012 Forecast - Quick Facts

Germany's Henkel AG & Co. KGaA (HENKY.PK, HENOY.PK) confirmed its full-year 2012 targets, still expecting organic sales growth to be between 3 percent and 5 percent. Also, the company continues to project to increase its 2012 adjusted EBIT margin to 14 percent and to improve adjusted earnings per preferred share by at least 10 percent.

Further, Henkel said it would propose to the Annual General Meeting to increase the dividend per preferred share from 0.72 euros - 0.80 euros and the dividend per ordinary share from 0.70 euros - 0.78 euros.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
This stock comes on our radar on the merit of its upbeat quarterly results. We believe the company has solid growth potential, as it expands through accretive acquisitions. In the next few-months, we see the stock touching new highs, and expect at least 20% upside from current levels. The month of February saw the FDA approve the second drug for Duchenne muscular dystrophy namely Emflaza. Now, let's take a look at the biotech stocks awaiting FDA decision in March. The recent week marked the lull before the storm, with very few market moving economic numbers released during the week. However, the economic news flow picks up pace in the upcoming week, offering glimpses into every vehicle of economic growth, ranging from consumers to private sector activity to housing....
comments powered by Disqus
Follow RTT